NEW!
BASIC AND CLINICAL PHARMACOLOGY 15TH
VK VK VK VK
EDITION KATZUNG TREVOR TEST BANK
VK VK VK VK VK
INCLUSIVE VKOF VKCHAPTERS VK1-66 VKCOMPLETE VKWITH VKEXPLAINED VKANSWERS
, Page VK2 VKof VK822
Basic and Clinical Pharmacology 15th Edition Katzung Trevor Test
VK VK VK VK VK VK VK VK
Bank
V K
Chapter VK1. VKIntroduction: VKThe VKNature VKof VKDrugs VK& VKDrug VKDevelopment VK& VKRegulation
1. A VKnurse VKworking VKin VKradiology VKadministers VKiodine VKto VKa VKpatient VKwho
VKis VKhaving VKa VKcomputed VKtomography VK(CT) VKscan. VKThe VKnurse VKworking
VKon VKthe VKoncology VKunit VKadministers VKchemotherapy VKto VKpatients VKwho
VKhave VKcancer. VKAt VKthe VKPublic VKHealth VKDepartment, VKa VKnurse
VKadministers VKa VKmeasles-mumps-rubella VK(MMR) VKvaccine VKto VKa VK14-
month-old VKchild VKas VKa VKroutine VKimmunization. VKWhich VKbranch VKof
VKpharmacology VKbest VKdescribes VKthe VKactions VKof VKall VKthree V K nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Feedback:
Pharmacology VKis VKthe VKstudy VKof VKthe VKbiologic VKeffects VKof VKchemicals.
VKNurses VKare VKinvolved VKwith VKclinical VKpharmacology VKor
VKpharmacotherapeutics, VKwhich VKis VKa VKbranch VKof VKpharmacology VKthat
VKdeals VKwith VKthe VKuses VKof VKdrugs VKto VKtreat, VKprevent, VKand VKdiagnose
VKdisease. VKThe VKradiology VKnurse VKis VKadministering VKa VKdrug VKto VKhelp
VKdiagnose VKa VKdisease. VKThe VKoncology VKnurse VKis VKadministering VKa VKdrug
VKto VKhelp VKtreat VKa VKdisease. VKPharmacoeconomics VKincludes VKany VKcosts
VKinvolved VKin VKdrug VKtherapy.
Pharmacodynamics VKinvolves VKhow VKa VKdrug VKaffects VKthe VKbody VKand
VKpharmacokinetics VKis VKhow VKthe VKbody VKacts VKon VKthe VKbody.
2. When VKinvolved VKin VKphase VKIII VKdrug VKevaluation
VKstudies, VKwhat VKresponsibilities VKwould VKthe VKnurse
VKhave?
A) Working VKwith VKanimals VKwho VKare VKgiven VKexperimental VK drugs
B) Choosing VKappropriate VKpatients VKto VKbe VKinvolved VKin VKthe VKdrug V K study
C) Monitoring VKand VKobserving VKpatients VKclosely VKfor VKadverse V K effects
,D) Conducting VKresearch VKto VKdetermine VKeffectiveness VKof VKthe V K drug
Page VK3 VKof VK822
Ans: C
Feedback:
Phase VKIII VKstudies VKinvolve VKuse VKof VKa VKdrug VKin VKa VKvast VKclinical
VKpopulation VKin VKwhich VKpatients VKare VKasked VKto VKrecord VKany VKsymptoms
VKthey VKexperience VKwhile VKtaking VKthe VKdrugs. VKNurses VKmay VKbe
VKresponsible VKfor VKhelping VKcollect VKand VKanalyze VKthe VKinformation VKto VKbe
VKshared VKwith VKthe VKFood VKand VKDrug VKAdministration VK(FDA) VKbut VKwould
VKnot VKconduct VKresearch VKindependently VKbecause VKnurses VKdo VKnot
VKprescribe VKmedications. VKUse VKof VKanimals VKin VKdrug VKtesting VKis VKdone VKin
VKthe VKpreclinical VKtrials. VKSelect VKpatients VKwho VKare VKinvolved VKin VKphase
VKII VKstudies VKto VKparticipate VKin VKstudies VKwhere VKthe VKparticipants VKhave
VKthe VKdisease VKthe VKdrug VKis VKintended VKto VKtreat. VKThese VKpatients VKare
VKmonitored VKclosely VKfor VKdrug VKaction VKand VKadverse VKeffects. VKPhase VKI
VKstudies VKinvolve VKhealthy VKhuman VKvolunteers VKwho VKare VKusually VKpaid
VKfor VKtheir VKparticipation. VKNurses VKmay VKobserve VKfor VKadverse VKeffects
VKand VKtoxicity.
3. A VKphysician VKhas VKordered VKintramuscular VK(IM) VKinjections VKof
VKmorphine, VKa VKnarcotic, VKevery VK4 VKhours VKas VKneeded VKfor VKpain VKin VKa
VKmotor VKvehicle VKaccident VKvictim. VKThe VKnurse VKis VKaware VKthis VKdrug VKhas
VKa VKhigh VKabuse VKpotential. VKUnder VKwhat VKcategory VKwould VKmorphine VKbe
VKclassified?
A) Schedule VKI
B) Schedule VKII
C) Schedule VKIII
D) Schedule VKIV
Ans: B
Feedback:
, Narcotics VKwith VKa VKhigh VKabuse VKpotential VKare VKclassified VKas VKSchedule
VKII VKdrugs VKbecause VKof VKsevere VKdependence VKliability. VKSchedule VKI
VKdrugs VKhave VKhigh VKabuse VKpotential VKand VKno VKaccepted VKmedical VKuse.
VKSchedule VKIII VKdrugs VKhave VKa VKlesser VKabuse VKpotential VKthan VKII VKand VKan
VKaccepted VKmedical VKuse. VKSchedule VKIV VKdrugs VKhave VKlow VKabuse
VKpotential VKand VKlimited VKdependence VKliability.
4. What VKconcept VKis VKconsidered VKwhen VKgeneric VKdrugs VKare VKsubstituted
VKfor VKbrand VKname VKdrugs?
A) Bioavailability
Page VK4 VKof VK822
B) Critical VKconcentration
C) Distribution
D) Half-life
Ans: A
Feedback:
Bioavailability VKis VKthe VKportion VKof VKa VKdose VKof VKa VKdrug VKthat VKreaches
VKthe VKsystemic VKcirculation VKand VKis VKavailable VKto VKact VKon VKbody VKcells.
VKBinders VKused VKin VKa VKgeneric VKdrug VKmay VKnot VKbe VKthe VKsame VKas
VKthose VKused VKin VKthe VKbrand VKname VKdrug. VKTherefore, VKthe VKway VKthe
VKbody VKbreaks VKdown VKand VKuses VKthe VKdrug VKmay VKdiffer, VKwhich VKmay
VKeliminate VKa VKgeneric VKdrug VKsubstitution. VKCritical VKconcentration VKis VKthe
VKamount VKof VKa VKdrug VKthat VKis VKneeded VKto VKcause VKa VKtherapeutic VKeffect
VKand VKshould VKnot VKdiffer VKbetween VKgeneric VKand VKbrand VKname
VKmedications. VKDistribution VKis VKthe VKphase VKof VKpharmacokinetics, VKwhich
VKinvolves VKthe VKmovement VKof VKa VKdrug VKto VKthe VKbodys VKtissues VKand VKis
VKthe VKsame VKin VKgeneric VKand VKbrand VKname VKdrugs. VKA VKdrugs VKhalf-life VKis
VKthe VKtime VKit VKtakes VKfor VKthe VKamount VKof VKdrug VKto VKdecrease VKto VKhalf
VKthe VKpeak VKlevel, VKwhich VKshould VKnot VKchange VKwhen VKsubstituting VKa
VKgeneric V K medication.
5. A VKnurse VKis VKassessing VKthe VKpatients VKhome VKmedication VKuse. VKAfter
VKlistening VKto VKthe VKpatient VKlist VKcurrent VKmedications, VKthe VKnurse VKasks
VKwhat VKpriority VKquestion?
A) Do VKyou VKtake VKany VKgeneric VKmedications?
B) Are VKany VKof VKthese VKmedications VKorphan VKdrugs?
C) Are VKthese VKmedications VKsafe VKto VKtake VKduring VKpregnancy?
BASIC AND CLINICAL PHARMACOLOGY 15TH
VK VK VK VK
EDITION KATZUNG TREVOR TEST BANK
VK VK VK VK VK
INCLUSIVE VKOF VKCHAPTERS VK1-66 VKCOMPLETE VKWITH VKEXPLAINED VKANSWERS
, Page VK2 VKof VK822
Basic and Clinical Pharmacology 15th Edition Katzung Trevor Test
VK VK VK VK VK VK VK VK
Bank
V K
Chapter VK1. VKIntroduction: VKThe VKNature VKof VKDrugs VK& VKDrug VKDevelopment VK& VKRegulation
1. A VKnurse VKworking VKin VKradiology VKadministers VKiodine VKto VKa VKpatient VKwho
VKis VKhaving VKa VKcomputed VKtomography VK(CT) VKscan. VKThe VKnurse VKworking
VKon VKthe VKoncology VKunit VKadministers VKchemotherapy VKto VKpatients VKwho
VKhave VKcancer. VKAt VKthe VKPublic VKHealth VKDepartment, VKa VKnurse
VKadministers VKa VKmeasles-mumps-rubella VK(MMR) VKvaccine VKto VKa VK14-
month-old VKchild VKas VKa VKroutine VKimmunization. VKWhich VKbranch VKof
VKpharmacology VKbest VKdescribes VKthe VKactions VKof VKall VKthree V K nurses?
A) Pharmacoeconomics
B) Pharmacotherapeutics
C) Pharmacodynamics
D) Pharmacokinetics
Ans: B
Feedback:
Pharmacology VKis VKthe VKstudy VKof VKthe VKbiologic VKeffects VKof VKchemicals.
VKNurses VKare VKinvolved VKwith VKclinical VKpharmacology VKor
VKpharmacotherapeutics, VKwhich VKis VKa VKbranch VKof VKpharmacology VKthat
VKdeals VKwith VKthe VKuses VKof VKdrugs VKto VKtreat, VKprevent, VKand VKdiagnose
VKdisease. VKThe VKradiology VKnurse VKis VKadministering VKa VKdrug VKto VKhelp
VKdiagnose VKa VKdisease. VKThe VKoncology VKnurse VKis VKadministering VKa VKdrug
VKto VKhelp VKtreat VKa VKdisease. VKPharmacoeconomics VKincludes VKany VKcosts
VKinvolved VKin VKdrug VKtherapy.
Pharmacodynamics VKinvolves VKhow VKa VKdrug VKaffects VKthe VKbody VKand
VKpharmacokinetics VKis VKhow VKthe VKbody VKacts VKon VKthe VKbody.
2. When VKinvolved VKin VKphase VKIII VKdrug VKevaluation
VKstudies, VKwhat VKresponsibilities VKwould VKthe VKnurse
VKhave?
A) Working VKwith VKanimals VKwho VKare VKgiven VKexperimental VK drugs
B) Choosing VKappropriate VKpatients VKto VKbe VKinvolved VKin VKthe VKdrug V K study
C) Monitoring VKand VKobserving VKpatients VKclosely VKfor VKadverse V K effects
,D) Conducting VKresearch VKto VKdetermine VKeffectiveness VKof VKthe V K drug
Page VK3 VKof VK822
Ans: C
Feedback:
Phase VKIII VKstudies VKinvolve VKuse VKof VKa VKdrug VKin VKa VKvast VKclinical
VKpopulation VKin VKwhich VKpatients VKare VKasked VKto VKrecord VKany VKsymptoms
VKthey VKexperience VKwhile VKtaking VKthe VKdrugs. VKNurses VKmay VKbe
VKresponsible VKfor VKhelping VKcollect VKand VKanalyze VKthe VKinformation VKto VKbe
VKshared VKwith VKthe VKFood VKand VKDrug VKAdministration VK(FDA) VKbut VKwould
VKnot VKconduct VKresearch VKindependently VKbecause VKnurses VKdo VKnot
VKprescribe VKmedications. VKUse VKof VKanimals VKin VKdrug VKtesting VKis VKdone VKin
VKthe VKpreclinical VKtrials. VKSelect VKpatients VKwho VKare VKinvolved VKin VKphase
VKII VKstudies VKto VKparticipate VKin VKstudies VKwhere VKthe VKparticipants VKhave
VKthe VKdisease VKthe VKdrug VKis VKintended VKto VKtreat. VKThese VKpatients VKare
VKmonitored VKclosely VKfor VKdrug VKaction VKand VKadverse VKeffects. VKPhase VKI
VKstudies VKinvolve VKhealthy VKhuman VKvolunteers VKwho VKare VKusually VKpaid
VKfor VKtheir VKparticipation. VKNurses VKmay VKobserve VKfor VKadverse VKeffects
VKand VKtoxicity.
3. A VKphysician VKhas VKordered VKintramuscular VK(IM) VKinjections VKof
VKmorphine, VKa VKnarcotic, VKevery VK4 VKhours VKas VKneeded VKfor VKpain VKin VKa
VKmotor VKvehicle VKaccident VKvictim. VKThe VKnurse VKis VKaware VKthis VKdrug VKhas
VKa VKhigh VKabuse VKpotential. VKUnder VKwhat VKcategory VKwould VKmorphine VKbe
VKclassified?
A) Schedule VKI
B) Schedule VKII
C) Schedule VKIII
D) Schedule VKIV
Ans: B
Feedback:
, Narcotics VKwith VKa VKhigh VKabuse VKpotential VKare VKclassified VKas VKSchedule
VKII VKdrugs VKbecause VKof VKsevere VKdependence VKliability. VKSchedule VKI
VKdrugs VKhave VKhigh VKabuse VKpotential VKand VKno VKaccepted VKmedical VKuse.
VKSchedule VKIII VKdrugs VKhave VKa VKlesser VKabuse VKpotential VKthan VKII VKand VKan
VKaccepted VKmedical VKuse. VKSchedule VKIV VKdrugs VKhave VKlow VKabuse
VKpotential VKand VKlimited VKdependence VKliability.
4. What VKconcept VKis VKconsidered VKwhen VKgeneric VKdrugs VKare VKsubstituted
VKfor VKbrand VKname VKdrugs?
A) Bioavailability
Page VK4 VKof VK822
B) Critical VKconcentration
C) Distribution
D) Half-life
Ans: A
Feedback:
Bioavailability VKis VKthe VKportion VKof VKa VKdose VKof VKa VKdrug VKthat VKreaches
VKthe VKsystemic VKcirculation VKand VKis VKavailable VKto VKact VKon VKbody VKcells.
VKBinders VKused VKin VKa VKgeneric VKdrug VKmay VKnot VKbe VKthe VKsame VKas
VKthose VKused VKin VKthe VKbrand VKname VKdrug. VKTherefore, VKthe VKway VKthe
VKbody VKbreaks VKdown VKand VKuses VKthe VKdrug VKmay VKdiffer, VKwhich VKmay
VKeliminate VKa VKgeneric VKdrug VKsubstitution. VKCritical VKconcentration VKis VKthe
VKamount VKof VKa VKdrug VKthat VKis VKneeded VKto VKcause VKa VKtherapeutic VKeffect
VKand VKshould VKnot VKdiffer VKbetween VKgeneric VKand VKbrand VKname
VKmedications. VKDistribution VKis VKthe VKphase VKof VKpharmacokinetics, VKwhich
VKinvolves VKthe VKmovement VKof VKa VKdrug VKto VKthe VKbodys VKtissues VKand VKis
VKthe VKsame VKin VKgeneric VKand VKbrand VKname VKdrugs. VKA VKdrugs VKhalf-life VKis
VKthe VKtime VKit VKtakes VKfor VKthe VKamount VKof VKdrug VKto VKdecrease VKto VKhalf
VKthe VKpeak VKlevel, VKwhich VKshould VKnot VKchange VKwhen VKsubstituting VKa
VKgeneric V K medication.
5. A VKnurse VKis VKassessing VKthe VKpatients VKhome VKmedication VKuse. VKAfter
VKlistening VKto VKthe VKpatient VKlist VKcurrent VKmedications, VKthe VKnurse VKasks
VKwhat VKpriority VKquestion?
A) Do VKyou VKtake VKany VKgeneric VKmedications?
B) Are VKany VKof VKthese VKmedications VKorphan VKdrugs?
C) Are VKthese VKmedications VKsafe VKto VKtake VKduring VKpregnancy?
